Diagnostyka S.A. (WSE:DIA)
Poland · Delayed Price · Currency is PLN 168.80
-0.90 (-0.53%)
At close: Aug 14, 2026
Diagnostyka Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Operating Revenue | 2,490 | 2,410 | 1,950 | 1,588 |
Other Revenue | 21.11 | 13.77 | 24.54 | - |
| 2,511 | 2,424 | 1,975 | 1,588 | |
Revenue Growth | 20.19% | 22.77% | 24.35% | - |
Cost of Revenue | 520.7 | 505.03 | 420 | 401.71 |
Gross Profit | 1,990 | 1,919 | 1,555 | 1,186 |
Selling, General & Admin | 1,323 | 1,275 | 1,014 | 773.99 |
Other Operating Expenses | 60.66 | 58.85 | 42.14 | 35.06 |
Operating Expenses | 1,597 | 1,537 | 1,217 | 959.44 |
Operating Income | 393.54 | 382.7 | 338.01 | 226.83 |
Interest Expense | -69.35 | -68.86 | -57.37 | -54.2 |
Interest & Investment Income | 0.93 | - | - | 2.01 |
Earnings From Equity Investments | -0.01 | -0.19 | 1.61 | 0.06 |
Other Non Operating Income (Expenses) | 3 | 3.23 | 8.94 | -1.55 |
EBT Excluding Unusual Items | 327.83 | 316.88 | 291.19 | 173.16 |
Gain (Loss) on Sale of Investments | - | - | - | -4.98 |
Gain (Loss) on Sale of Assets | - | - | - | 3.53 |
Legal Settlements | - | - | - | -0.15 |
Other Unusual Items | - | - | - | 2.07 |
Pretax Income | 327.83 | 316.88 | 291.19 | 173.62 |
Income Tax Expense | 55.14 | 55.01 | 59.24 | 43.63 |
Earnings From Continuing Operations | 272.69 | 261.87 | 231.96 | 129.99 |
Minority Interest in Earnings | -11.39 | -10.27 | -8.63 | -6.56 |
Net Income | 261.3 | 251.6 | 223.33 | 123.43 |
Net Income to Common | 261.3 | 251.6 | 223.33 | 123.43 |
Net Income Growth | 12.65% | 12.66% | 80.93% | - |
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 |
Shares Change | - | - | - | - |
EPS (Basic) | 7.74 | 7.45 | 6.62 | 3.66 |
EPS (Diluted) | 7.74 | 7.45 | 6.62 | 3.66 |
EPS Growth | 12.64% | 12.61% | 80.93% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | 357.42 | 346.99 | 282.72 | 254.66 |
Free Cash Flow Per Share | 10.59 | 10.28 | 8.38 | 7.54 |
Dividend Per Share | 4.400 | 4.400 | 3.310 | - |
Dividend Growth | 32.93% | 32.93% | - | - |
Gross Margin | 79.26% | 79.17% | 78.73% | 74.70% |
Operating Margin | 15.67% | 15.79% | 17.12% | 14.28% |
Profit Margin | 10.41% | 10.38% | 11.31% | 7.77% |
Free Cash Flow Margin | 14.24% | 14.31% | 14.32% | 16.04% |
EBITDA | 604.81 | 584.5 | 499.54 | 275.58 |
EBITDA Margin | 24.09% | 24.11% | 25.30% | 17.35% |
D&A For EBITDA | 211.28 | 201.79 | 161.53 | 48.75 |
EBIT | 393.54 | 382.7 | 338.01 | 226.83 |
EBIT Margin | 15.67% | 15.79% | 17.12% | 14.28% |
Effective Tax Rate | 16.82% | 17.36% | 20.34% | 25.13% |
Revenue as Reported | 2,511 | 2,424 | 1,975 | 1,597 |